Body Mass Index (BMI) is often used to assess body weight and determine a person’s risk of developing heart disease, diabetes, and stroke.  Pixabay/pexels
Fitness and Wellness

Is BMI Getting Obesity Wrong? New Global Research Backs a More Detailed Approach to Diagnosis, Risk Assessment, and Patient Care

A groundbreaking two-stage diagnostic model distinguishes between clinical and pre-clinical obesity, preventing millions of misdiagnoses and paving the way for truly personalized healthcare

Author : Akanksha

The two-stage diagnostic model can be used to distinguish between clinical and pre-clinical obesity, reducing the number of incorrect diagnoses and enabling individualised care. 

The Inaccuracies of Body Mass Index (BMI) in Obesity Diagnosis

In medical practice, Body Mass Index (BMI) is often used to assess body weight and determine a person’s risk of developing heart disease, diabetes, and stroke. However, it is not a precise measure of body weight. It cannot be used to determine where excess fat may be located in the body, or even whether someone actually has excess fat. Furthermore, it does not take into consideration different body types. 

An accurate diagnosis of obesity is very important in order to give optimal treatment to patients. Using BMI alone to diagnose obesity can lead to incorrect assumptions for many people. 

A recent study involving 844,108 adults from four countries found that BMI alone sometimes incorrectly identifies obesity. It overestimated obesity in 1.2–3.1% of participants and failed to identify excess body fat in 5.2–8.6% of participants. This shows that relying only on BMI can lead to both incorrect obesity diagnoses and missed cases of excess body fat.2

This presents major public health problems, as patients can be either over-treated or under-treated. 

A New Diagnostic Method for Obesity (2025)

A new method of diagnosing obesity was proposed by a commission in the Lancet Diabetes and Endocrinology journal 2025.1 This method has recently been put to the test by an international group of scientists, including those from King’s College, London, and Huazhong University of Science and Technology. 

Using health data from 844,108 adults from China, the U.K., the U.S.A., and Spain over 15 years, scientists validated this new method of diagnosing obesity. The research has been published in the journal Nature and describes a two-stage method of diagnosis.2

Also Read: Body Processes Good Fats and Bad Fats Differently, UCLA Health Study Finds

Stage 1: Waist Measurement as an Alternative to BMI

This diagnostic step allows medical professionals to confirm with certainty whether a patient has dangerous levels of excess fat. Those with a BMI of 40 or higher will automatically be diagnosed with obesity. However, for people with a lower BMI (between 25 and 29.9, or a baseline of 30), additional physical measurements are required. 

In the 2026 Nature study, researchers operationalised the combined anthropometric criteria using BMI alongside waist circumference and waist-to-height ratio, with different thresholds for Chinese participants and other ethnic groups.

Measuring the waist size or waist-to-height ratio allows medical professionals to accurately determine if a patient has excess fat. This means that people without harmful excess fat distribution will no longer be wrongly diagnosed with obesity solely based on their BMI. 

Stage 2: Distinguishing Pre-clinical and Clinical Obesity

This stage determines whether having excess fat is causing problems in the body’s internal systems. It allows people to be classified into one of the two categories:

  • Clinical Obesity: Having excess fat that is causing serious damage to organs or impairing normal bodily functions. 

  • Pre-Clinical Obesity: Having excess fat that may cause health problems in the future, but whose organs and bodily functions are completely unimpaired.

In the 2026 Nature study, researchers operationalised the combined anthropometric criteria using BMI alongside waist circumference and waist-to-height ratio, with different thresholds for Chinese participants and other ethnic groups.

Findings from the Global Study on Excess Body Fat

The data from this global study showed large differences in prognosis between patients. It was found that only one-quarter to one-third of people diagnosed with obesity, equating to 5.6-10.9% of the general population, were actually classed as having clinical obesity. However, those with clinical obesity had a 69% increased risk of death compared to those with no excess fat.2 

On the other hand, people with pre-clinical obesity had a much smaller increased risk of death, 19%. Encouragingly, 77-91% of people with pre-clinical obesity did not develop clinical obesity within 10 years.2 

Also Read: The Higher Your Body Fat Percentage, The Less Accurate Your Smartwatch is at Measuring Calories You Burn When Exercising – New Study

GLP-1 Drugs and the Future of Individualised Care 

Professor Francesco Rubino, chair of metabolic and bariatric surgery at King’s College, London, explains that using this new method of diagnosing obesity, healthcare systems can provide optimal care to the patients without over-treating or under-treating them. Knowing how high a risk a patient is facing in terms of organ damage allows medical professionals to tailor treatment exactly to that individual in the press release. 

Rather than giving highly aggressive treatments, such as GLP-1 weight loss drugs or bariatric surgery, to all people in a certain BMI category, these powerful treatments can be specifically given to people suffering from an active disease. Those with pre-clinical obesity can be given very specific preventative advice depending on how high a risk they face. 

By moving away from relying solely on BMI, this two-stage method of diagnosis could help medical professionals distinguish between people who have excess adiposity and those who are already experiencing obesity-related functional impairment. Using this two-stage method of diagnosis allows medical professionals to give people with obesity the exact amount of care they need. 

References:

  1. Pan, A., S. Yang, R. Ramos, et al. “Validation of Clinical and Preclinical Obesity across Global Cohorts.” Nature (2026). 

    https://www.nature.com/articles/s41586-026-11237-5.

  2. Hwang, J. H., and N. Laiteerapong. “Beyond BMI: The Impact of the New Lancet Commission Diagnostic Criteria on Prevalence of Obesity in the United States.” Obesity 34, suppl. 1 (2026): 29–42. 

    https://pmc.ncbi.nlm.nih.gov/articles/PMC13250740/.

(Rh/APC/MSM)

Why Data Security Is Essential in Modern Patient Care

Bittu Tabahi Develops Skin Problems After Months of Cleaning Polluted Ajnar River

Feel Dizzy at the Grocery Store? Understanding Supermarket Syndrome and Visually Induced Dizziness

25-Year-Old Doctor Found Dead in Maharashtra After Missing NEET-PG Counselling Seat

UK Zero-Hours Contract Reforms: Why NHS and Fire Services Fear Higher Staffing Costs and Disruption to Emergency Services